BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28034376)

  • 1. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
    Pandey A; Kim S; Moore C; Thomas L; Gersh B; Allen LA; Kowey PR; Mahaffey KW; Hylek E; Peterson ED; Piccini JP; Fonarow GC;
    JACC Heart Fail; 2017 Jan; 5(1):44-52. PubMed ID: 28034376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study.
    Buckley LF; Agha AM; Dorbala P; Claggett BL; Yu B; Hussain A; Nambi V; Chen LY; Matsushita K; Hoogeveen RC; Ballantyne CM; Shah AM
    Circ Heart Fail; 2023 Nov; 16(11):e010849. PubMed ID: 37753653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction.
    McManus DD; Hsu G; Sung SH; Saczynski JS; Smith DH; Magid DJ; Gurwitz JH; Goldberg RJ; Go AS;
    J Am Heart Assoc; 2013 Feb; 2(1):e005694. PubMed ID: 23525446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
    Longhi S; Quarta CC; Milandri A; Lorenzini M; Gagliardi C; Manuzzi L; Bacchi-Reggiani ML; Leone O; Ferlini A; Russo A; Gallelli I; Rapezzi C
    Amyloid; 2015; 22(3):147-55. PubMed ID: 25997105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation type and long-term clinical outcomes in hospitalized patients with heart failure: insight from JROADHF.
    Hamatani Y; Enzan N; Iguchi M; Yoshizawa T; Kawaji T; Ide T; Tohyama T; Matsushima S; Abe M; Tsutsui H; Akao M
    Eur Heart J Qual Care Clin Outcomes; 2024 May; 10(3):193-202. PubMed ID: 38236704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
    Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
    Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Steinberg BA; Kim S; Fonarow GC; Thomas L; Ansell J; Kowey PR; Mahaffey KW; Gersh BJ; Hylek E; Naccarelli G; Go AS; Reiffel J; Chang P; Peterson ED; Piccini JP
    Am Heart J; 2014 May; 167(5):735-42.e2. PubMed ID: 24766985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.
    Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Maggioni AP; Latini R; Carson PE; Singh SN; Barlera S; Glazer R; Masson S; Cerè E; Tognoni G; Cohn JN;
    Am Heart J; 2005 Mar; 149(3):548-57. PubMed ID: 15864246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.
    Zakeri R; Chamberlain AM; Roger VL; Redfield MM
    Circulation; 2013 Sep; 128(10):1085-93. PubMed ID: 23908348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Eur J Heart Fail; 2015 Jun; 17(6):570-82. PubMed ID: 25727992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment for incident heart failure in individuals with atrial fibrillation.
    Schnabel RB; Rienstra M; Sullivan LM; Sun JX; Moser CB; Levy D; Pencina MJ; Fontes JD; Magnani JW; McManus DD; Lubitz SA; Tadros TM; Wang TJ; Ellinor PT; Vasan RS; Benjamin EJ
    Eur J Heart Fail; 2013 Aug; 15(8):843-9. PubMed ID: 23594831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of heart failure subtypes and atrial fibrillation: Data from the Atherosclerosis Risk in Communities (ARIC) study.
    Nji MAM; Solomon SD; Chen LY; Shah AM; Soliman EZ; Alam AB; Subramanya V; Alonso A
    Int J Cardiol; 2021 Sep; 339():47-53. PubMed ID: 34246724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of get with the guidelines-heart failure.
    Mountantonakis SE; Grau-Sepulveda MV; Bhatt DL; Hernandez AF; Peterson ED; Fonarow GC
    Circ Heart Fail; 2012 Mar; 5(2):191-201. PubMed ID: 22361078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure in patients with atrial fibrillation is associated with a high symptom and hospitalization burden: the RealiseAF survey.
    Silva-Cardoso J; Zharinov OJ; Ponikowski P; Naditch-Brûlé L; Lewalter T; Brette S; Steg PG;
    Clin Cardiol; 2013 Dec; 36(12):766-74. PubMed ID: 24105492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation.
    Suzuki S; Sagara K; Otsuka T; Matsuno S; Funada R; Uejima T; Oikawa Y; Yajima J; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
    Am J Cardiol; 2012 Sep; 110(5):678-82. PubMed ID: 22621797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE project.
    Rehm M; Rothenbacher D; Iacoviello L; Costanzo S; Tunstall-Pedoe H; Fitton CA; Söderberg S; Hultdin J; Salomaa V; Jousilahti P; Palosaari T; Kuulasmaa K; Waldeyer C; Schnabel RB; Zeller T; Blankenberg S; Koenig W;
    ESC Heart Fail; 2022 Feb; 9(1):57-65. PubMed ID: 34825788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in patients hospitalized with permanent and nonpermanent atrial fibrillation in heart failure.
    Taillandier S; Brunet Bernard A; Lallemand B; Simeon E; Pericart L; Clementy N; Babuty D; Fauchier L
    Am J Cardiol; 2014 Apr; 113(7):1189-95. PubMed ID: 24507167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.